(EPHE) MSCI Philippines - Overview

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46429B4086

Etf: Equities, Large-Cap, Mid-Cap, Small-Cap

Total Rating 28
Risk 77
Buy Signal 0.43

Dividends

Dividend Yield 1.98%
Yield on Cost 5y 1.80%
Yield CAGR 5y 12.05%
Payout Consistency 90.0%
Payout Ratio -
Risk 5d forecast
Volatility 16.3%
Relative Tail Risk 2.24%
Reward TTM
Sharpe Ratio 0.39
Alpha 0.90
Character TTM
Beta 0.417
Beta Downside 0.436
Drawdowns 3y
Max DD 21.42%
CAGR/Max DD 0.00

Description: EPHE MSCI Philippines January 20, 2026

The iShares MSCI Philippines ETF (NYSE ARCA: EPHE) commits at least 80% of its net assets to the securities that compose the MSCI Philippines Index, or to assets that closely mimic those securities’ economic characteristics. The index is free-float-adjusted and market-cap weighted, covering large, mid, and small-cap Philippine equities, and the fund is classified as non-diversified under U.S. regulations.

As of the most recent filing, EPHE carries an expense ratio of roughly 0.48% and manages about $200 million in assets, reflecting modest but growing investor interest in the Philippines market. The Philippine economy has been expanding at an annualized rate near 5-6% in 2023, driven primarily by strong services (especially Business Process Outsourcing), robust remittance inflows, and a recovering manufacturing sector-factors that underpin the underlying index’s performance.

For a deeper quantitative breakdown of EPHE’s risk-return profile, you might explore ValueRay’s analytics platform.

What is the price of EPHE shares?

As of February 08, 2026, the stock is trading at USD 26.73 with a total of 64,375 shares traded.
Over the past week, the price has changed by +2.93%, over one month by +2.89%, over three months by +11.76% and over the past year by +10.26%.

Is EPHE a buy, sell or hold?

MSCI Philippines has no consensus analysts rating.

What are the forecasts/targets for the EPHE price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 29.2 9.4%

EPHE Fundamental Data Overview February 04, 2026

Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 156.4m USD (156.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 156.4m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 156.4m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.45% (E(156.4m)/V(156.4m) * Re(7.45%) + (debt-free company))
Discount Rate = 7.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for EPHE ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle